OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2
İsmail Çeli̇k, Abbas Khan, Fenny Martha Dwivany, et al.
Molecular Diversity (2022) Vol. 26, Iss. 6, pp. 3309-3324
Closed Access | Times Cited: 25
İsmail Çeli̇k, Abbas Khan, Fenny Martha Dwivany, et al.
Molecular Diversity (2022) Vol. 26, Iss. 6, pp. 3309-3324
Closed Access | Times Cited: 25
Showing 25 citing articles:
SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?
Sheeba Saifi, Varsha Ravi, Sparsh Sharma, et al.
Genomics (2022) Vol. 114, Iss. 5, pp. 110466-110466
Open Access | Times Cited: 29
Sheeba Saifi, Varsha Ravi, Sparsh Sharma, et al.
Genomics (2022) Vol. 114, Iss. 5, pp. 110466-110466
Open Access | Times Cited: 29
The Impact of Mutation Sets in Receptor-Binding Domain of SARS-CoV-2 Variants on Stability of the RBD–ACE2 Complex
Mykyta Peka, Viktor Balatsky
Future Virology (2023) Vol. 18, Iss. 4, pp. 225-242
Open Access | Times Cited: 9
Mykyta Peka, Viktor Balatsky
Future Virology (2023) Vol. 18, Iss. 4, pp. 225-242
Open Access | Times Cited: 9
Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the Interaction with the ACE2 Protein
Mariem Ghoula, Audrey Deyawe Kongmeneck, Rita Eid, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 40, pp. 8586-8602
Open Access | Times Cited: 7
Mariem Ghoula, Audrey Deyawe Kongmeneck, Rita Eid, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 40, pp. 8586-8602
Open Access | Times Cited: 7
A computational simulation appraisal of banana lectin as a potential anti-SARS-CoV-2 candidate by targeting the receptor-binding domain
Sofia Safitri Hessel, Fenny Martha Dwivany, Ima Mulyama Zainuddin, et al.
Journal of Genetic Engineering and Biotechnology (2023) Vol. 21, Iss. 1, pp. 148-148
Open Access | Times Cited: 5
Sofia Safitri Hessel, Fenny Martha Dwivany, Ima Mulyama Zainuddin, et al.
Journal of Genetic Engineering and Biotechnology (2023) Vol. 21, Iss. 1, pp. 148-148
Open Access | Times Cited: 5
Structure-guided engineering and molecular simulations to design a potent monoclonal antibody to target aP2 antigen for adaptive immune response instigation against type 2 diabetes
Abbas Khan, Muhammad Zahid, Anwar Mohammad, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Abbas Khan, Muhammad Zahid, Anwar Mohammad, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as an Important Scaffold for Anticancer Drug Discovery—In Vitro and In Silico Evaluation
Mateusz Kciuk, Beata Marciniak, İsmail Çeli̇k, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10959-10959
Open Access | Times Cited: 4
Mateusz Kciuk, Beata Marciniak, İsmail Çeli̇k, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10959-10959
Open Access | Times Cited: 4
Genomic and structural mechanistic insight to reveal the differential infectivity of omicron and other variants of concern
Priyanka Sharma, Mukesh Kumar, Manish Tripathi, et al.
Computers in Biology and Medicine (2022) Vol. 150, pp. 106129-106129
Open Access | Times Cited: 8
Priyanka Sharma, Mukesh Kumar, Manish Tripathi, et al.
Computers in Biology and Medicine (2022) Vol. 150, pp. 106129-106129
Open Access | Times Cited: 8
Prediction of infectivity of SARS-CoV2: Mathematical model with analysis of docking simulation for spike proteins and angiotensin-converting enzyme 2
Yutaka Takaoka, Aki Sugano, Yoshitomo Morinaga, et al.
Microbial Risk Analysis (2022) Vol. 22, pp. 100227-100227
Open Access | Times Cited: 6
Yutaka Takaoka, Aki Sugano, Yoshitomo Morinaga, et al.
Microbial Risk Analysis (2022) Vol. 22, pp. 100227-100227
Open Access | Times Cited: 6
Mutational analysis of catalytic site domain of CCHFV L RNA segment
Neha Kaushal, Manoj Baranwal
Journal of Molecular Modeling (2023) Vol. 29, Iss. 4
Open Access | Times Cited: 2
Neha Kaushal, Manoj Baranwal
Journal of Molecular Modeling (2023) Vol. 29, Iss. 4
Open Access | Times Cited: 2
Bond strength between receptor binding domain of spike protein and human angiotensin converting enzyme-2 using machine learning.
Abdulmateen Adebiyi, Puja Adhikari, Praveen Rao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Abdulmateen Adebiyi, Puja Adhikari, Praveen Rao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A network pharmacology approach to elucidate the anti-inflammatory and antioxidant effects of bitter leaf (Vernonia amygdalina Del.)
Illah Sailah, Trina Ekawati Tallei, Linda Safitri, et al.
Narra J (2024) Vol. 4, Iss. 3, pp. e1016-e1016
Open Access
Illah Sailah, Trina Ekawati Tallei, Linda Safitri, et al.
Narra J (2024) Vol. 4, Iss. 3, pp. e1016-e1016
Open Access
High-Throughput Molecular Dynamics-Based Alchemical Free Energy Calculations for Predicting the Binding Free Energy Change Associated with the Selected Omicron Mutations in the Spike Receptor-Binding Domain of SARS-CoV-2
Rajendra Bhadane, Outi M. H. Salo‐Ahen
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2779-2779
Open Access | Times Cited: 3
Rajendra Bhadane, Outi M. H. Salo‐Ahen
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2779-2779
Open Access | Times Cited: 3
Structural plasticity of omicron BA.5 and BA.2.75 for enhanced ACE-dependent entry into cells
Junqi Lin, Farwa Anjum Huma, Aiza Irfan, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 20, pp. 10762-10773
Open Access | Times Cited: 3
Junqi Lin, Farwa Anjum Huma, Aiza Irfan, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 20, pp. 10762-10773
Open Access | Times Cited: 3
Mutation-Induced Changes in the Stability, B-Cell Epitope, and Antigenicity of the Sars-Cov-2 Variant Spike Protein: A Comparative Computational Stud
Nira Meirita Wijayanti, Muhammad Hermawan Widyananda, Lailil Muflikhah, et al.
Karbala International Journal of Modern Science (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 1
Nira Meirita Wijayanti, Muhammad Hermawan Widyananda, Lailil Muflikhah, et al.
Karbala International Journal of Modern Science (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 1
Low-Entropy Hydration Shells at the Spike RBD’s Binding Site May Reveal the Contagiousness of SARS-CoV-2 Variants
Lin Yang, Shuai Guo, Chengyu Hou, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1628-1628
Open Access | Times Cited: 1
Lin Yang, Shuai Guo, Chengyu Hou, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1628-1628
Open Access | Times Cited: 1
Immunoinformatics-Driven Strategies for Advancing Epitope-Based Vaccine Design for West Nile Virus
Axl Laurens Lukas Windah, Trina Ekawati Tallei, Bashayer M. AlShehail, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 4, pp. 906-917
Open Access | Times Cited: 1
Axl Laurens Lukas Windah, Trina Ekawati Tallei, Bashayer M. AlShehail, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 4, pp. 906-917
Open Access | Times Cited: 1
Prediction of infectivity of SARS-CoV2: Mathematical model with analysis of docking simulation for spike proteins and angiotensin-converting enzyme 2
Yutaka Takaoka, Aki Sugano, Yoshitomo Morinaga, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Yutaka Takaoka, Aki Sugano, Yoshitomo Morinaga, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Design of a chimeric ACE-2/Fc-silent fusion protein with ultrahigh affinity and neutralizing capacity for SARS-CoV-2 variants
Neil M. Bodie, Rina Hashimoto, David Connolly, et al.
Antibody Therapeutics (2023) Vol. 6, Iss. 1, pp. 59-74
Open Access
Neil M. Bodie, Rina Hashimoto, David Connolly, et al.
Antibody Therapeutics (2023) Vol. 6, Iss. 1, pp. 59-74
Open Access
Serum neutralization of SARS-CoV-2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in individuals receiving Evusheld
Qianqian Zhao, Xin Wang, Ze Zhang, et al.
Research Square (Research Square) (2023)
Open Access
Qianqian Zhao, Xin Wang, Ze Zhang, et al.
Research Square (Research Square) (2023)
Open Access
Emerging XBB variants in Vietnam show high affinity for hACE2
Quan Ke Thai, Phuoc Huynh
GSC Biological and Pharmaceutical Sciences (2023) Vol. 23, Iss. 3, pp. 231-236
Open Access
Quan Ke Thai, Phuoc Huynh
GSC Biological and Pharmaceutical Sciences (2023) Vol. 23, Iss. 3, pp. 231-236
Open Access
Molecular evolution and adaptation of SARS-CoV-2 omicron XBB sub-lineage Spike protein under African Selection pressure.
Milton S Kambarami, Godwins Ngorima, Praise Moyo, et al.
(2023)
Open Access
Milton S Kambarami, Godwins Ngorima, Praise Moyo, et al.
(2023)
Open Access
DESIGN OF A CHIMERIC ACE-2/Fc-SILENT FUSION PROTEIN WITH ULTRAHIGH AFFINITY AND NEUTRALIZING CAPACITY FOR SARS-CoV-2 VARIANTS
Neil M. Bodie, David Connolly, Jennifer Chu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Neil M. Bodie, David Connolly, Jennifer Chu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access